ArticleJournal of gastroenterology2026
Agonistic GITR treatment enhances antitumor immune responses and suppresses tumor progression in pancreatic ductal adenocarcinoma.
Steve Robatel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.